China is putting the brakes on a rush of humanoid-robot companies seeking stock-market listings, as regulators scrutinize soaring valuations and question whether revenue tied to state-backed projects represents sustainable commercial demand.
People familiar with the matter told Reuters that Chinese regulators have used informal “window guidance” to discourage some humanoid-robot companies from pursuing IPOs, raising the bar for listings in one of the country’s most aggressively promoted technology sectors. One person said humanoid IPOs had effectively been frozen for now, while another described the move as a sector-specific slowdown rather than a formal ban.
The regulatory caution was triggered in part by the volatile performance of Unitree Robotics, one of China’s best-known humanoid and quadruped robot makers. Its shares surged more than fivefold in their Shanghai debut last month before retreating 55% from their peak.
Register for the next Tekedia Mini-MBA.
Register for Tekedia AI in Business Masterclass.
Join Tekedia Capital Syndicate and co-invest in great global startups.
The episode has exposed a tension at the heart of China’s robotics industry. Beijing has made “embodied intelligence”, or AI systems capable of perceiving and acting in the physical world, a strategic emerging industry. That policy support has helped channel private capital and local-government funding into humanoid robotics, but it has also encouraged a rush of companies and investors into a sector where commercial deployment remains relatively limited.
The regulatory response therefore appears aimed less at slowing the underlying technology than at imposing a higher threshold for companies seeking access to public markets. The approach seems to be part of Beijing’s plan to develop a domestic robotics industry while avoiding the kind of speculative excess that can leave retail investors bearing the losses when expectations move faster than actual demand.
Leo Wang, a venture capitalist at Qianchuang Capital, described the investment wave as “campaign-style innovation”, a term used in China for periods when companies and capital rapidly concentrate around a policy-favored industry.
Wang said enthusiasm around embodied AI had exceeded that seen during China’s earlier internet and new-energy investment waves. Industrial-robot manufacturers have been shifting towards humanoid machines, while startups have attracted rapidly rising valuations. Some founders, he said, have attracted dozens of potential investors within weeks and resisted conventional due diligence. Some private-market projects have already suffered valuation cuts of 30% to 50%.
At the center of regulators’ concerns is the quality of revenue.
One person close to humanoid-robot investors said authorities were examining whether income generated through local-government-backed projects could be sustained. Robot data-collection centers and joint ventures, in which local governments can provide 80% to 90% of initial investment, have generated significant revenue for some companies.
Such arrangements can help companies build sales figures, support private-market valuations and satisfy financial thresholds for an IPO. But regulators are now asking a more fundamental question: how much of that demand comes from customers buying robots because they need them, rather than from government programmes designed to promote the industry?
That is expected to materially alter how some companies are valued. The person estimated that valuations at some robotics companies could fall 60% to 70% if revenue associated with data-collection centers were removed.
That scrutiny is also spilling into the public market. Mech-Mind Robotics CEO Shao Tianlan alleged in a WeChat post this month that some highly valued embodied-AI companies were generating revenue through data-collection centers, related-party transactions and other arrangements that may not be sustainable as they race towards IPOs. Shao declined to comment beyond the post.
Shares in Mech-Mind have fallen nearly 20% from their debut-day high on September 1, another indication that investors are becoming more selective even as the broader robotics narrative remains strong.
At least half a dozen Chinese humanoid-robot companies are preparing to go public, including Deep Robotics, X Square Robot and AGIBOT. None immediately responded to Reuters’ requests for comment on whether regulators had slowed their listing plans.
The scrutiny marks a significant change in the financing environment. For much of the year, the major question for investors was how quickly China’s humanoid-robot industry could scale. The focus is now shifting towards whether individual companies can prove that their robots are being deployed at meaningful volumes, generate repeat orders, and eventually produce sustainable profits.
Ruiying Zhao, a senior research analyst at S&P Global Market Intelligence, described the change in sentiment as a move from “blanket euphoria to selective rationality”, with investors paying greater attention to whether realized commercial value justifies high valuations.
That shift does not necessarily undermine China’s broader robotics ambitions. Instead, it could force the industry to move from demonstrations and policy-backed deployments towards measurable commercial use.
The situation is gaining wider interest as companies attempt to turn impressive demonstrations into industrial businesses. A robot that can run, dance or perform a complex maneuver can attract enormous attention, but the economics of the sector will ultimately depend on whether manufacturers can sell large numbers of machines that reliably perform useful tasks in factories, warehouses, logistics operations and other commercial environments.
A senior banker involved in Asian equity offerings said investors remained willing to finance robotics companies but were demanding more evidence of deployment, volumes and valuations.
“What’s the use case? Is it just people’s robots dancing around? Is it working in factories?” the banker said. “The volume hasn’t really caught up with the hype.”
That question goes to the heart of China’s next phase of the humanoid-robot boom. The country has already demonstrated that policy support, manufacturing capacity and abundant capital can accelerate the development of an emerging technology. The harder test is whether those advantages can produce an industry whose revenues are driven increasingly by independent customers rather than government-backed programmes.
Beijing is now facing the challenge to maintain momentum in a technology viewed as strategically important while preventing the capital market from getting too far ahead of the underlying business. Unitree’s rapid rise and subsequent fall have provided an early warning of what can happen when public-market expectations move faster than commercial adoption.
The result is likely to be a more demanding IPO environment for China’s humanoid-robot sector. Companies may now have to show not only that their technology works, but that customers are willing to pay for it repeatedly and at sufficient scale to justify the valuations attached to the industry’s next generation of public companies.